James L. Gulley
Papers
1
Total Citations
8
H-Index
1
About
Dr. James L. Gulley is a leading oncologist and researcher whose work centers on the intersection of immunotherapy and genitourinary cancers, particularly prostate cancer. His major contributions include pioneering the use of immune-based therapies, such as vaccine strategies and checkpoint inhibitors, to treat advanced prostate cancer, often in combination with standard hormonal therapies. Notably, his research on the role of multiparametric MRI (mpMRI) in preoperative staging for men undergoing androgen deprivation therapy and robotic prostatectomy has helped refine treatment planning, as highlighted in his 2019 study (8 citations). While his citation counts reflect focused clinical impact, Dr. Gulley's broader influence is evident in his leadership at the National Cancer Institute, where he has advanced clinical trials exploring novel combinations of immunotherapy and targeted agents. His work has been instrumental in shifting the paradigm from purely cytotoxic treatments to integrating immune modulation, offering new hope for patients with resistant disease. A prolific author and speaker, Dr. Gulley continues to shape the future of urologic oncology through translational research that bridges laboratory discoveries and bedside care.
Research Focus
Key Achievements
Top Papers
- 1